News
FDA Approves First Twice-a-Year HIV Prevention Shot
Made by Gilead Sciences and sold under the name Yeztugo, the drug gives people a new way to stay protected from HIV without needing daily pills or frequent injections, The New York Times reported. “We’re on the precipice of now being able to deliver the greatest prevention option we’ve had in 44 years of this epidemic,
A new Lyme disease vaccine, VLA15, is currently being tested and the manufacturers could ask the FDA for authorization as ...
The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...
The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the ...
A newly posted agenda for next week’s meeting of the just-appointed group of outside vaccine advisers to the US Centers for ...
Vinay Prasad, the FDA’s freshly appointed head of vaccines, has been named chief medical and scientific officer, taking on ...
The Tdap vaccine provides essential protection against tetanus, diphtheria, and pertussis, playing a critical role in ...
The approach employed by the research team could be used against other diseases—including COVID-19 and influenza.
The FDA expanded the approval of Moderna’s RSV vaccine, extending the license to include more adults and giving the company a ...
Offit, who sits on the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC), made the comments after criticizing Health and Human Services (HHS) Secretary Robert F. Kennedy Jr.
The Food and Drug Administration expanded the approval of Moderna’s RSV vaccine on Thursday, extending the license to include ...
One of the most effective vaccines available was going to become more accessible—until RFK Jr. dismissed the CDC’s advisory ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback